MENU
RIGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Rigel Pharmaceuticals (RIGL) Earnings Date & Reports
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
RIGL is expected to report earnings to fall 53.25% to 20 cents per share on August 04
Q2'26
Est.
$0.21
Q1'26
Beat
by $0.58
Q4'25
Beat
by $13.52
Q3'25
Beat
by $1.45
Q2'25
Beat
by $3.31
The last earnings report on May 05 showed earnings per share of 43 cents, beating the estimate of -14 cents. With 885.24K shares outstanding, the current market capitalization sits at 716.40M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical-stage drug development company that discovers and develops novel, small-molecule drugs
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
174
Web
https://www.rigel.com